Alzheimer’s is set to cost Australia $26.6 billion…
With upcoming World Alzheimer’s Day (21st Sep) the focus on healthy ageing has never been greater.
Expected to rise by more than 70% to around $26.6 billion over the next 20 years, here’s why we need to consider the significance of early detection and what it can mean:
- Worryingly, only 19% of Australians aged between 40-74 prioritise brain health as their number 1 health priority, while 61% wouldn’t consult a GP or pharmacist if they had troubles remembering names of people they had met recently
- 45% of Australians aged 40-74 have never heard of mild cognitive impairment (MCI)
- Dementia is the leading cause of death for women and early detection of MCI can mean a world of difference
Leading community pharmacist for over 50 years, Gerald Quigley shares that a combination of healthy diet, regular physical activity and social interaction, in addition to appropriate use of Food for Special Medical Purposes Souvenaid is essential to positive ageing as well as the upkeep of treating Mild Cognitive Impairment (MCI).
Recently awarded product of the Year: Omega-3 category at the Nutra Ingredients Asia Awards 2022, Souvenaid is a clinically proven medical nutrition drink containing a specific combination of fatty acids, vitamins and nutrients proven to slow the decline in memory and cognition by 60% in the early stage of Alzheimer’s disease when taken daily over three years. In a recent new Aussie survey commissioned by Nutricia, insights into MCI and brain health have revealed Aussie’s do not prioritise brain health, despite it being the second leading cause of death in Australia.